Thoracic -deficient undifferentiated tumors are rare, with poor prognosis. A 73-year-old man presented to our hospital with dyspnea. Computed tomography-guided biopsy revealed a -deficient undifferentiated tumor. The patient was treated with combination ipilimumab-nivolumab. The tumor reduced in size after two courses.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748223 | PMC |
http://dx.doi.org/10.1002/ccr3.6745 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!